FFCP PHASE2:Hg19::chr5:89770664..89770688,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p2@POLR3G |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_POLR3G_5end |
Coexpression cluster: | C2832_iPS_mesothelioma_testicular_teratocarcinoma_H9_HES3GFP_giant |
Association with transcript: | 0bp_to_ENST00000399107, ENST00000503973, NM_006467, uc003kjq.2, uc011cuc.1_5end |
EntrezGene: | POLR3G |
HGNC: | 30075 |
UniProt: | O15318D6R921 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@POLR3G |
---|
0
5
10
15
20
25
30
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
disease of cellular proliferation | 3.89e-12 | 239 |
hematologic cancer | 5.74e-12 | 51 |
immune system cancer | 5.74e-12 | 51 |
cancer | 1.45e-11 | 235 |
leukemia | 2.82e-09 | 39 |
myeloid leukemia | 9.16e-07 | 31 |
Showing 1 to 6 of 6 entries